Standout Papers
- Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study (2000)
- Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer (2005)
Immediate Impact
1 by Nobel laureates 6 from Science/Nature 85 standout
Citing Papers
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
Y chromosome loss in cancer drives growth by evasion of adaptive immunity
2023 StandoutNature
Works of T. Oliver being referenced
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
2000 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| T. Oliver | 2752 | 640 | 1161 | 16 | 3.3k | |
| Michael J. Morse | 2390 | 884 | 651 | 31 | 2.9k | |
| Lisa Sengeløv | 2085 | 1033 | 1414 | 45 | 3.4k | |
| Karl‐Heinz Kurth | 3190 | 529 | 648 | 41 | 4.0k | |
| Lora Weiselberg | 1371 | 668 | 804 | 33 | 2.4k | |
| Eduardo Solsona | 2664 | 395 | 575 | 37 | 3.1k | |
| C Bouffioux | 3104 | 568 | 592 | 52 | 3.8k | |
| Erkki Rintala | 2104 | 462 | 556 | 40 | 2.6k | |
| Otakar Čapoun | 3898 | 823 | 893 | 47 | 4.5k | |
| Donald W. W. Newling | 2385 | 331 | 450 | 10 | 2.6k | |
| C.J. van Groeningen | 996 | 583 | 1072 | 49 | 2.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...